ALKHOURI, N., NADEEM, R., LEFF, P., MANTRY, P., QUIAMBAO, R., DUPUY, J., . . . DE LEDINGHEN, V. (2024). 1322-P: Combination of LiverSTAT (LST) and Fibroscan (LSM) Outperforms FIB-4 and LSM for MASLD Advanced Fibrosis (AF) F3F4. Diabetes (New York, N.Y.), 73(Supplement_1), 1. https://doi.org/10.2337/db24-1322-P
Chicago Style (17th ed.) CitationALKHOURI, NAIM, RIDA NADEEM, PHILLIP LEFF, PARVEZ MANTRY, RONALD QUIAMBAO, JULIE DUPUY, MONA MUNTEANU, and VICTOR DE LEDINGHEN. "1322-P: Combination of LiverSTAT (LST) and Fibroscan (LSM) Outperforms FIB-4 and LSM for MASLD Advanced Fibrosis (AF) F3F4." Diabetes (New York, N.Y.) 73, no. Supplement_1 (2024): 1. https://doi.org/10.2337/db24-1322-P.
MLA (9th ed.) CitationALKHOURI, NAIM, et al. "1322-P: Combination of LiverSTAT (LST) and Fibroscan (LSM) Outperforms FIB-4 and LSM for MASLD Advanced Fibrosis (AF) F3F4." Diabetes (New York, N.Y.), vol. 73, no. Supplement_1, 2024, p. 1, https://doi.org/10.2337/db24-1322-P.